Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Picconi

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2012
New synaptic and molecular targets for neuroprotection in Parkinson's diseasePaolo Calabresi, Massimiliano Di Filippo, Antongiulio Gallina, et al.
The European Journal of Neuroscience|September 25, 2002
Tissue plasminogen activator is required for corticostriatal long-term potentiationDiego Centonze, Maddalena Napolitano, Emilia Saulle, et al.
Neurobiology of Disease|November 13, 2007
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiationBarbara Picconi, Vincent Paillé, Veronica Ghiglieri, et al.
Cell Death Discovery|October 17, 2021
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney diseaseGiuseppina Natale, Valeria Calabrese, Gioia Marino, et al.
Cephalalgia : an International Journal of Headache|March 30, 2019
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regionsAntonio de Iure, Petra Mazzocchetti, Guendalina Bastioli, et al.
Neurobiology of Disease|December 6, 2005
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneuronsBarbara Picconi, Enrica Passino, Carmelo Sgobio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2019
Dopamine drives binge-like consumption of a palatable food in experimental ParkinsonismDésirée Mineo, Fabrizio Cacace, Maria Mancini, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonismDaniella Rylander, Vincenza Bagetta, Valentina Pendolino, et al.
Annals of Neurology|October 26, 2018
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving conceptsAlberto J Espay, Francesca Morgante, Aristide Merola, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2009
Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depressionFabrizio Gardoni, Daniela Mauceri, Matteo Malinverno, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2012
New synaptic and molecular targets for neuroprotection in Parkinson's diseasePaolo Calabresi, Massimiliano Di Filippo, Antongiulio Gallina, et al.
The European Journal of Neuroscience|September 25, 2002
Tissue plasminogen activator is required for corticostriatal long-term potentiationDiego Centonze, Maddalena Napolitano, Emilia Saulle, et al.
Neurobiology of Disease|November 13, 2007
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiationBarbara Picconi, Vincent Paillé, Veronica Ghiglieri, et al.
Cell Death Discovery|October 17, 2021
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney diseaseGiuseppina Natale, Valeria Calabrese, Gioia Marino, et al.
Cephalalgia : an International Journal of Headache|March 30, 2019
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regionsAntonio de Iure, Petra Mazzocchetti, Guendalina Bastioli, et al.
Neurobiology of Disease|December 6, 2005
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneuronsBarbara Picconi, Enrica Passino, Carmelo Sgobio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2019
Dopamine drives binge-like consumption of a palatable food in experimental ParkinsonismDésirée Mineo, Fabrizio Cacace, Maria Mancini, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonismDaniella Rylander, Vincenza Bagetta, Valentina Pendolino, et al.
Annals of Neurology|October 26, 2018
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving conceptsAlberto J Espay, Francesca Morgante, Aristide Merola, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2009
Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depressionFabrizio Gardoni, Daniela Mauceri, Matteo Malinverno, et al.
Pageof 14